{"protocolSection":{"identificationModule":{"nctId":"NCT00636766","orgStudyIdInfo":{"id":"887/2005"},"organization":{"fullName":"Aristotle University Of Thessaloniki","class":"OTHER"},"briefTitle":"Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque","officialTitle":"Atherosclerotic Plaque Texture-Experimental and Clinical Study on the Diagnostic and Therapeutic Strategies of Atherosclerotic Plaque Vulnerability"},"statusModule":{"statusVerifiedDate":"2012-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-09"},"primaryCompletionDateStruct":{"date":"2007-12","type":"ACTUAL"},"completionDateStruct":{"date":"2009-01","type":"ACTUAL"},"studyFirstSubmitDate":"2008-03-11","studyFirstSubmitQcDate":"2008-03-11","studyFirstPostDateStruct":{"date":"2008-03-14","type":"ESTIMATED"},"lastUpdateSubmitDate":"2012-11-01","lastUpdatePostDateStruct":{"date":"2012-11-02","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Nikolaos Kadoglou","investigatorTitle":"MD,PhD","investigatorAffiliation":"Aristotle University Of Thessaloniki"},"leadSponsor":{"name":"Aristotle University Of Thessaloniki","class":"OTHER"}},"descriptionModule":{"briefSummary":"The aim of the present study is to examine the atherosclerotic plaque stability using in vivo and in vitro techniques and to investigate the influence of exercise, anti-diabetic, lipid-lowering and cannabinoids receptor antagonists on atherosclerotic plaque texture in patients with cardiovascular risk and animals prone to atherosclerosis."},"conditionsModule":{"conditions":["Carotid Atherosclerosis","Stroke","Type 2 Diabetes","Metabolic Syndrome"],"keywords":["cardiovascular events"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"FACTORIAL","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":300,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Drug: atorvastatin","Drug: rimonabant","Drug: rosiglitazone","Drug: metformin"]}],"interventions":[{"type":"DRUG","name":"atorvastatin","description":"A:Experimental study of atherosclerosis B1:Effects of exercise on experimental atherosclerosis B2:Effects of exercise on high risk patients C1:Effects of statins on atherosclerotic plaque stability (experimental) C2:Effects of statins on atherosclerotic plaque stability (clinical) D:Effects of rosiglitazone and metformin on cardiovascular risk factors E:Effects of rimonabant on atherosclerotic plaque stability (experimental)","armGroupLabels":["1"]},{"type":"DRUG","name":"rimonabant","description":"A:Experimental study of atherosclerosis B1:Effects of exercise on experimental atherosclerosis B2:Effects of exercise on high risk patients C1:Effects of statins on atherosclerotic plaque stability (experimental) C2:Effects of statins on atherosclerotic plaque stability (clinical) D:Effects of rosiglitazone and metformin on cardiovascular risk factors E:Effects of rimonabant on atherosclerotic plaque stability (experimental)","armGroupLabels":["1"]},{"type":"DRUG","name":"rosiglitazone","description":"A:Experimental study of atherosclerosis B1:Effects of exercise on experimental atherosclerosis B2:Effects of exercise on high risk patients C1:Effects of statins on atherosclerotic plaque stability (experimental) C2:Effects of statins on atherosclerotic plaque stability (clinical) D:Effects of rosiglitazone and metformin on cardiovascular risk factors E:Effects of rimonabant on atherosclerotic plaque stability (experimental)","armGroupLabels":["1"]},{"type":"DRUG","name":"metformin","description":"A:Experimental study of atherosclerosis B1:Effects of exercise on experimental atherosclerosis B2:Effects of exercise on high risk patients C1:Effects of statins on atherosclerotic plaque stability (experimental) C2:Effects of statins on atherosclerotic plaque stability (clinical) D:Effects of rosiglitazone and metformin on cardiovascular risk factors E:Effects of rimonabant on atherosclerotic plaque stability (experimental)","armGroupLabels":["1"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Ultrasound and immunohistochemical parameters of plaque stability; novel cardiovascular risk factors","timeFrame":"3 years"}],"secondaryOutcomes":[{"measure":"Long-term cardiovascular outcomes","timeFrame":"3 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Carotid atherosclerosis\n* Femoral atherosclerosis\n* Cardiovascular risk\n\nExclusion Criteria:\n\n* Heart failure\n* Renal disease\n* Liver disease\n* Life-threatening diseases","healthyVolunteers":true,"sex":"ALL","minimumAge":"50 Years","maximumAge":"80 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Christos Liapis, Professor","affiliation":"University of Athens","role":"STUDY_CHAIR"}],"locations":[{"facility":"General Hospital of Thessaloniki \"Hippokratio\"","city":"Thessaloniki","country":"Greece","geoPoint":{"lat":40.64361,"lon":22.93086}}]},"referencesModule":{"references":[{"pmid":"25453890","type":"DERIVED","citation":"Kadoglou NP, Moulakakis KG, Papadakis I, Ikonomidis I, Alepaki M, Spathis A, Karakitsos P, Lekakis J, Liapis CD. Differential effects of stent-graft fabrics on arterial stiffness in patients undergoing endovascular aneurysm repair. J Endovasc Ther. 2014 Dec;21(6):850-8. doi: 10.1583/14-4772MR.1."},{"pmid":"25264981","type":"DERIVED","citation":"Moustardas P, Kadoglou NP, Katsimpoulas M, Kapelouzou A, Kostomitsopoulos N, Karayannacos PE, Kostakis A, Liapis CD. The complementary effects of atorvastatin and exercise treatment on the composition and stability of the atherosclerotic plaques in ApoE knockout mice. PLoS One. 2014 Sep 29;9(9):e108240. doi: 10.1371/journal.pone.0108240. eCollection 2014."},{"pmid":"25142320","type":"DERIVED","citation":"Lambadiari V, Kadoglou NP, Stasinos V, Maratou E, Antoniadis A, Kolokathis F, Parissis J, Hatziagelaki E, Iliodromitis EK, Dimitriadis G. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol. 2014 Aug 21;13:121. doi: 10.1186/s12933-014-0121-z."},{"pmid":"25022935","type":"DERIVED","citation":"Kadoglou NP, Tahmatzidis DK, Giannakoulas C, Kapelouzou A, Gkontopoulos A, Parissis J, Lampropoulos S, Kottas G. Serum levels of novel adipokines, omentin-1 and chemerin, in patients with acute myocardial infarction: KOZANI STUDY. J Cardiovasc Med (Hagerstown). 2015 May;16(5):341-6. doi: 10.2459/JCM.0000000000000053."},{"pmid":"24956535","type":"DERIVED","citation":"Kadoglou NP, Lambadiari V, Gastounioti A, Gkekas C, Giannakopoulos TG, Koulia K, Maratou E, Alepaki M, Kakisis J, Karakitsos P, Nikita KS, Dimitriadis G, Liapis CD. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability. Atherosclerosis. 2014 Aug;235(2):606-12. doi: 10.1016/j.atherosclerosis.2014.05.957. Epub 2014 Jun 8."},{"pmid":"24768795","type":"DERIVED","citation":"Kadoglou NP, Fotiadis G, Lambadiari V, Maratou E, Dimitriadis G, Liapis CD. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis. Peptides. 2014 Jul;57:12-6. doi: 10.1016/j.peptides.2014.04.008. Epub 2014 Apr 24."},{"pmid":"24464597","type":"DERIVED","citation":"Kadoglou NP, Sailer N, Fotiadis G, Kapelouzou A, Liapis CD. The impact of type 2 diabetes and atorvastatin treatment on serum levels of MMP-7 and MMP-8. Exp Clin Endocrinol Diabetes. 2014 Jan;122(1):44-9. doi: 10.1055/s-0033-1358762. Epub 2014 Jan 24."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000002340","term":"Carotid Artery Diseases"},{"id":"D000050197","term":"Atherosclerosis"},{"id":"D000024821","term":"Metabolic Syndrome"},{"id":"D000058226","term":"Plaque, Atherosclerotic"}],"ancestors":[{"id":"D000007333","term":"Insulin Resistance"},{"id":"D000006946","term":"Hyperinsulinism"},{"id":"D000044882","term":"Glucose Metabolism Disorders"},{"id":"D000008659","term":"Metabolic Diseases"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000020763","term":"Pathological Conditions, Anatomical"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6805","name":"Diabetes Mellitus","relevance":"LOW"},{"id":"M6809","name":"Diabetes Mellitus, Type 2","relevance":"LOW"},{"id":"M22695","name":"Metabolic Syndrome","asFound":"Metabolic Syndrome","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M25878","name":"Atherosclerosis","asFound":"Atherosclerosis","relevance":"HIGH"},{"id":"M28693","name":"Plaque, Atherosclerotic","asFound":"Atherosclerotic Plaque","relevance":"HIGH"},{"id":"M5284","name":"Carotid Artery Diseases","asFound":"Carotid Atherosclerosis","relevance":"HIGH"},{"id":"M10060","name":"Insulin Resistance","relevance":"LOW"},{"id":"M9687","name":"Hyperinsulinism","relevance":"LOW"},{"id":"M11329","name":"Metabolic Diseases","relevance":"LOW"},{"id":"M25093","name":"Glucose Metabolism Disorders","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M22209","name":"Pathological Conditions, Anatomical","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC18","name":"Nutritional and Metabolic Diseases"},{"abbrev":"BC19","name":"Gland and Hormone Related Diseases"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000008687","term":"Metformin"},{"id":"D000077154","term":"Rosiglitazone"},{"id":"D000077285","term":"Rimonabant"},{"id":"D000069059","term":"Atorvastatin"}],"ancestors":[{"id":"D000007004","term":"Hypoglycemic Agents"},{"id":"D000045505","term":"Physiological Effects of Drugs"},{"id":"D000000924","term":"Anticholesteremic Agents"},{"id":"D000000960","term":"Hypolipidemic Agents"},{"id":"D000000963","term":"Antimetabolites"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"},{"id":"D000057847","term":"Lipid Regulating Agents"},{"id":"D000019161","term":"Hydroxymethylglutaryl-CoA Reductase Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000019440","term":"Anti-Obesity Agents"},{"id":"D000063387","term":"Cannabinoid Receptor Antagonists"},{"id":"D000063385","term":"Cannabinoid Receptor Modulators"},{"id":"D000018377","term":"Neurotransmitter Agents"},{"id":"D000006728","term":"Hormones"},{"id":"D000006730","term":"Hormones, Hormone Substitutes, and Hormone Antagonists"}],"browseLeaves":[{"id":"M11357","name":"Metformin","asFound":"Post-","relevance":"HIGH"},{"id":"M351","name":"Atorvastatin","asFound":"Functional","relevance":"HIGH"},{"id":"M20845","name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","relevance":"LOW"},{"id":"M1739","name":"Rimonabant","asFound":"PI3K","relevance":"HIGH"},{"id":"M1677","name":"Rosiglitazone","asFound":"Renal Cell","relevance":"HIGH"},{"id":"M9744","name":"Hypoglycemic Agents","relevance":"LOW"},{"id":"M3933","name":"Anticholesteremic Agents","relevance":"LOW"},{"id":"M3968","name":"Hypolipidemic Agents","relevance":"LOW"},{"id":"M3971","name":"Antimetabolites","relevance":"LOW"},{"id":"M28573","name":"Lipid Regulating Agents","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"M21086","name":"Anti-Obesity Agents","relevance":"LOW"},{"id":"M20194","name":"Neurotransmitter Agents","relevance":"LOW"},{"id":"M9479","name":"Hormones","relevance":"LOW"},{"id":"M9478","name":"Hormone Antagonists","relevance":"LOW"}],"browseBranches":[{"abbrev":"Hypo","name":"Hypoglycemic Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Lipd","name":"Lipid Regulating Agents"},{"abbrev":"AnObAg","name":"Anti-Obesity Agents"}]}},"hasResults":false}